Correlation Between Passage Bio and Structure Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Structure Therapeutics American, you can compare the effects of market volatilities on Passage Bio and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Structure Therapeutics.

Diversification Opportunities for Passage Bio and Structure Therapeutics

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Passage and Structure is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Passage Bio i.e., Passage Bio and Structure Therapeutics go up and down completely randomly.

Pair Corralation between Passage Bio and Structure Therapeutics

Given the investment horizon of 90 days Passage Bio is expected to under-perform the Structure Therapeutics. In addition to that, Passage Bio is 1.2 times more volatile than Structure Therapeutics American. It trades about -0.5 of its total potential returns per unit of risk. Structure Therapeutics American is currently generating about 0.14 per unit of volatility. If you would invest  2,819  in Structure Therapeutics American on November 2, 2024 and sell it today you would earn a total of  213.00  from holding Structure Therapeutics American or generate 7.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Passage Bio  vs.  Structure Therapeutics America

 Performance 
       Timeline  
Passage Bio 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Passage Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Passage Bio reported solid returns over the last few months and may actually be approaching a breakup point.
Structure Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Passage Bio and Structure Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Passage Bio and Structure Therapeutics

The main advantage of trading using opposite Passage Bio and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.
The idea behind Passage Bio and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins